Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-230979
Filing Date
2011-08-24
Accepted
2011-08-24 16:19:17
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1002758
2 SIXTH AMENDMENT EXTENSION AGREEMENT DATED FEBRUARY 11, 2011 dex1035.htm EX-10.35 24614
3 SUBSIDIARIES OF THE COMPANY dex211.htm EX-21.1 2175
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ERNST & YOUNG LLP dex231.htm EX-23.1 1778
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) dex311.htm EX-31.1 6233
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(A) dex312.htm EX-31.2 6479
7 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 3212
8 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 3418
9 GRAPHIC g224072g47c26.jpg GRAPHIC 59971
  Complete submission text file 0001193125-11-230979.txt   1134425
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12104 | Film No.: 111054297
SIC: 2835 In Vitro & In Vivo Diagnostic Substances